Chitosan and marine phospholipids reduce matrix metalloproteinase activity in myeloma SP2 tumor-bearing mice

European Journal of Lipid Science and Technology

Volumn 111, Issue 9, 2009, Pages 877-883

  Hossain, Zakir ^a   Fukunaga, Kenji ^b   Tanouchi, Masatoshi ^c   Takahashi, Koretaro ^d  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI UNIVERSITY   (Japan)

^c Engineering Co   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Chitosan; Marine phospholipids; Matrix metalloproteinase; Myeloma SP2

Indexed keywords

ANIMALIA; CEPHALOPODA; MUS;

EID: 76749165763     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200700309     Document Type: Article

References (41)

1. O. Skaugrad, A. Hagen, B. Borgersen, M. Dornish: Biomedical and pharmaceutical application of alginate and chitosan. Biotechnol Genet Eng Rev. 1999, 16, 23-40.
2. R. Illum: Chitosan and its use as a pharmacological excipient. Pharm Res. 1998, 15, 1326-1331.
3. J. K. Suh, H. W. Matthew: Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review. Biomaterials. 2000, 21, 2589-2509.
4. A. Singla, M. Chawla: Chitosan. Some pharmaceutical and biological aspects - an update. J Pharm Pharmacol. 2000, 53, 1047-1067.
5. T. J. Aspden, J. Adler, S. S. Davis, Q. Skaugrud, L. Illum: Chitosan as a nasal delivery system: Evaluation of the effect of chitosan on mucociliary clearence rate in the frog palate model. Int J Pharm. 1995, 122, 69-78.
6. N. G. Schipper, K. M. Varum, P. Artursson: Chitosans as absorption enhancers for poorly absorbable drugs. 1. Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm Res. 1996, 13, 1686-1692.
7. st century. S T P Pharm Sci. 2000, 10, 5-22.
8. P. Berscht, B. Nies, A. Leibendorfer, J. Kreuter: In vitro evaluation of biocompatibility of different wound dressing materials. J Mater Sci Mater Med. 1995, 6, 201-205.
9. M. Dornish, A. Hagen, E. Hansson, C. Pecheur, F. Verdier, O. Skaugrad: Safety of Potasan: Ultrapure chitosan salts for biomedical and pharmaceutical use. Adv Chitin Sci. 1997, 2, 694-670.
10. H. Onishi, Y. Machida: Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials. 1999, 20, 175-182.
11. V. Dodane, K. M. Amin, J. Merwin: Effect of Caco-2 on epithelial permeability and structure. Int J Pharm. 1999, 182, 21-32.
12. J. Smith, M. Dornish, E. J. Wood: Effect of chitosan on epithelial cell tight junctions. Pharm Res. 2004, 21, 43-49.
13. R. Illum, P. Watts, A. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis, S. Davis: Intranasal delivery of morphine. J Pharm Exp Ther. 2002, 301, 391-400.
14. I. Degim, F. Acrturk, D. Erdogan, N. Lortlar: Transdermal administration of bromocriptine. Biol Pharm Bull. 2003, 26, 501-505.
15. M. L. González-Rodríguez, J. Barros, L. B. Palma, P. L. González-Rodríguez, A. M. Rabasco: Application of statistical experimental design to study the formulation variables influencing the coating process of lidocaine liposomes. Int J Pharm. 2007, 337, 336-345.
16. S. Mun, E. A. Decker, Y. Park, J. Weiss, D. J. McClements: Influence of interfacial composition on in vitro digestibility of emulsified lipids: Potential mechanism for chitosan's ability to inhibit fat digestion. Food Biophys. 2006, 1, 21-29.
17. P. K. Gupta, S.-H. S. Leung, J. R. Robinson: Bioadhesive/mucoadhesives in drug delivery to the gastrointestinal tract. In: Bioadhesive Drug Delivery Systems. Eds. V. Lenaerts, R. Gurny, CRC Press, Boca Raton, FL (USA) 1990, pp. 65-92.
18. E. Van Valckenborgh, P. I. Croucher, H. De Raeve, C. Carron, E. De Leenheer, S. Blacher, L. Devy, A. Noel, E. De Bruyne, K. Asosingh, I. Van Riet, B. Van Camp, K. Vanderkerken: Multifunctional role of matrix metalloproteinases in multiple myeloma: A study in the 5T2MM mouse model. Am J Pathol. 2004, 165, 869-878.
19. L. A. Marquez-Curtis, A. Dobrowski, J. Montano, A. R. Turner, J. Ratajczak, M. Z. Ratajczak, A. Janowska-Wieczorek: Matrix metalloproteinases and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal leukaemic longterm marrow cultures. Br J Haematol. 2001, 115, 595-604.
20. K. C. Anderson, T. J. Hamblin, A. Traynor: Management of multiple myeloma today. Semin Hematol. 1999, 36, 3-8.
21. C. Bain, A. Green, V. Siskind, J. Alexander, P. Harvey: Diet and melanoma: An exploratory case-control study. Ann Epidermiol. 1993, 3, 235-238.
22. Z. Hossain, M. Konishi, M. Hosokawa, K. Takahashi: Effect of polyunsaturated fatty acid-enriched phosphatidylcholine and phosphatidylserine on butyrate-induced growth inhibition, differentiation and apoptosis in Caco-2 cells. Cell Biochem Funct. 2006, 24, 159-165.
23. K. Augustsson, D. S. Michaud, E. B. Rimm, M. F. Leitzmann, M. J. Stampfer, W. C. Willett, E. Giovannucci: A prospective study intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003, 12, 64-67.
24. J. Filipović-Grčić,N.Škalko-Basnet, I. Jalšenjak: Mucoadhesive chitosan-coated liposomes: Characteristics and stability. J Microencapsul. 2001, 18, 3-12.
25. M. Hosokawa, T. Shimatani, T. Kanada, Y. Inoue, K. Takahashi: Conversion to docosahexaenoic acid-containing phosphatidylserine from squid skin lecithin by phospholipase Dmediated transphosphatidylation. J Agric Food Chem. 2000, 48, 4550-4554.
26. G. Lepage, C. C. Roy: Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986,27, 114-120.
27. K. Takahashi, T. Hirano, M. Saito: Application of partition chromatographic theory for the analysis of marine triglyceride molecular species. Nippon Suisan Gakkaishi. 1988, 54, 523-528.
28. K. Murakawa, K. Fukunaga, M. Tanouchi, M. Hosokawa, Z. Hossain, K. Takahashi: Therapy of myeloma in vivo using marine phospholipid in combination with Agaricus blazei Murill as an immune respond activator. J Oleo Sci. 2007, 54, 179-188.
29. E. Farias, S. Ranuncolo, C. Cresta, S. Specterman, E. Armanasco, M. Varela, J. Lastiri, M. G. Pallotta, E. Bal de Kier Joffe, L. Puricelli: Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. Int J Cancer. 2000, 89, 389-394.
30. H. Takeuchi, J. Thongborisute, Y. Matsui, H. Sugihara, H. Yamamoto, Y. Kawashima: Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Delivery Rev. 2005, 57, 1583-1594.
31. H. Takeuchi, H. Yamamoto, T. Niwa, T. Hino, Y. Kawashima: Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res. 1996, 13, 896-901.
32. H. Takeuchi, Y. Matsui, H. Yamamoto, Y. Kawashima: Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release. 2003, 86, 235-242.
33. C. Prego, M. Garcia, D. Torres, M. J. Alonso: Transmucosal macromolecular drug delivery. J Control Release. 2005, 101, 151-162.
34. N. G. M. Schipper, S. Olsson, J. A. Hoogstraate, A. G. deBeor, K. M. Varum, P. Artursson: Chitosans as absorption enhancers for poorly absorbable drug. 2. Mechanism of absorption enhancement. Pharm Res. 1997, 14, 923-929.
35. S. Barille, R. Bataille, M. Rapp, J. Harousseau, M. Amiot: Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J Immunol. 1999, 163, 5723-5728.
36. A. Vacca, D. Ribatti, M. Iurlaro, A. Albini, M. Minischetti, F. Bassolino, A. Pellegrino, R. Ria, M. Rusnati, M. Presta, V. Vincenti, M. G. Persico: Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res. 1998, 28, 55-68.
37. A. Vacca, D. Ribatti, M. Presta, M. Minischetti, M. Iularo, R. Ria, A. Albini, F. Bussolino, F. Dammacco: Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood. 1999, 93, 3064-3073.
38. A. Vacca, R. Ria, F. Semeraro, F. Merchionne, M. Coluccia, A. Boccarelli, C. Scavelli, B. Nico, A. Gemone, F. Battelli, A. Tabilio, D. Guidolin, M. T. Petrucci, D. Ribatti, F. Dammacco: Endothelial cells in the bone marrow of patients with multiple myeloma. Blood. 2003, 102, 3340-3348.
39. P. Vihinen, R. Ala-aho, V. M. Kahari: Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets. 2005, 5, 203-220.
40. E. Van Valckenborgh, D. Mincher, A. Di Salvo, I. Van Riet, L. Young, B. Van Camp, K. Vanderkerken: Targeting an MMP9-activated prodrug to multiple myeloma-diseased bone marrow: A proof of principle in the 5T33MM mouse model. Leukemia. 2005, 19, 1628-1633.
41. K. Kisano, C. Miyaura, M. Inada, T. Tamura, A. Ito, H. Nagase, K. Kamoi, T. Suda: Regulation of matrix metalloproteinases (MMP-2, -3, -9 and -13) by interleukin-1 and interleukin-6 in mouse calvaria: Association of MMP induction with bone resorption. Endocrinology. 1998, 139, 1338-1345.